Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Clin Pharm Ther ; 46(6): 1784-1786, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-33421160

RESUMO

WHAT IS KNOW AND OBJECTIVE: Teriflunomide is indicated for the treatment of adult patients with relapsing-remitting multiple sclerosis. CASE SUMMARY: We present a rare intoxication with a high dose (672 mg) of teriflunomide. According to its product label, the only known treatment is the administration of colestyramine and activated carbon (charcoal). No serious adverse events occurred during the time the patient was admitted (<24 h). No long-term overdose-related symptoms or complaints were reported. WHAT IS NEW AND CONCLUSION: The fact that after the acute overdose both adverse events and laboratory parameters were acceptable, prescribing colestyramine and activated carbon, as well as monitoring of laboratory parameters such as full blood count, liver and kidney values and QTc, seems sufficient during the early stage (<24 h after intake) of teriflunomide overdose.


Assuntos
Anti-Inflamatórios não Esteroides/toxicidade , Crotonatos/toxicidade , Overdose de Drogas/fisiopatologia , Hidroxibutiratos/toxicidade , Nitrilas/toxicidade , Toluidinas/toxicidade , Adulto , Antídotos/uso terapêutico , Carvão Vegetal/uso terapêutico , Resina de Colestiramina/uso terapêutico , Overdose de Drogas/tratamento farmacológico , Humanos , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA